SEARCH

SEARCH BY CITATION

References

  • 1
    Black RE. In: HolmgrenJ, LindbergA, MöllbyR eds.. The epidemiology of cholera and enterotoxigenic Escherichia coli diarrheal disease. Development of vaccines and drugs against diarrhea Studentlitteratur , Lund , 1986 2332.
  • 2
    Svennerholm A-M, Holmgren J, Sack DA. Development of oral vaccines against enterotoxigenic Escherichia coli diarrhea. Vaccine 1989; 7: 196198. 2675484
  • 3
    Jertborn M, Ahrén C, Holmgren J, Svennerholm A-M. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli vaccine. Vaccine 1997; 16: 255260.
  • 4
    Savarino SJ, Brown FM, Hall E et al. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli cholera toxin B-subunit vaccine in Egyptian adults. J Infect Dis 1998; 177: 796799. 9498468
  • 5
    Clemens J, Sack DA, Harris JR et al. Cross-protection by B-subunit whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large field trial. J Infect Dis 1988; 158: 372377. 3042876
  • 6
    Peltola H, Siitonen A, Kyrönseppa H et al. Prevention of travelers’ diarrhea by oral B-subunit/whole-cell cholera vaccine. Lancet 1991; 338: 12851289. 1682684
  • 7
    Binsztein N, Jouve MJ, Viboud G et al. Colonization factors in children with diarrhea in Argentina. J Clin Microbiol 1991; 29: 18931898. 1774313